tiprankstipranks
Trending News
More News >
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126

Compare JW (Cayman) Therapeutics Co. Ltd. (2126) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
JW (Cayman) Therapeutics Co. Ltd.
HK$2.50
HK$1.12B
-1.64
112.70%
Alphamab Oncology
HK$9.58
HK$10.65B
41.67
223.37%
2 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$9.91B
-47.34
123.11%
1 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$1.90B
-2.69
-52.12%
CStone Pharmaceuticals
HK$5.34
HK$8.41B
-18.58
163.18%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$9.48
HK$5.90B
153.40
12.59%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2126
JW (Cayman) Therapeutics Co. Ltd.
2.68
1.40
109.38%
HK:9966
Alphamab Oncology
10.93
7.70
238.39%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.33
3.06
134.80%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
3.96
-4.31
-52.12%
HK:2616
CStone Pharmaceuticals
5.79
3.70
177.03%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
9.48
0.79
9.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts